Rtw Investments, LP Uro Gen Pharma Ltd. Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Rtw Investments, LP holds 3,834,794 shares of URGN stock, worth $41.1 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
3,834,794
Previous 3,787,347
1.25%
Holding current value
$41.1 Million
Previous $48.1 Million
15.09%
% of portfolio
0.67%
Previous 0.77%
Shares
6 transactions
Others Institutions Holding URGN
# of Institutions
137Shares Held
36.2MCall Options Held
57.7KPut Options Held
9.8K-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$31.4 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$24.7 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$23.5 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$18.7 Million0.03% of portfolio
-
Vestal Point Capital, LP New York, NY1.63MShares$17.5 Million1.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $244M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...